Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine

Citation
Sh. Zaman et al., Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine, NEUROBIOL D, 7(1), 2000, pp. 54-63
Citations number
39
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROBIOLOGY OF DISEASE
ISSN journal
09699961 → ACNP
Volume
7
Issue
1
Year of publication
2000
Pages
54 - 63
Database
ISI
SICI code
0969-9961(200002)7:1<54:ESPITM>2.0.ZU;2-U
Abstract
Mutations in presenilin 1(PS1) are the most common causes of familial Alzhe imer's disease (FAD). We examined synaptic physiology in hippocampal brain slices of transgenic mice expressing the FAD-linked PS1 deletion of exon 9 variant. Basal excitatory transmission and paired-pulse facilitation in PS1 mutant mice were unchanged. Short- and long-term potentiation of excitator y transmission following high-frequency stimulation were greater in transge nic mice expressing mutant PS1. Mutants had enhanced synaptic inhibition, w hich may be a compensatory change offsetting an abnormally sensitized plast icity of excitatory transmission. Increasing inhibitory transmission in mut ant animals even more with a benzodiazepine reverted synaptic potentiation to the levels of controls. These results support the potential use of benzo diazepines in the treatment of familial Alzheimer's disease. (C) 2000 Acade mic Press.